Agenda: Life Sciences Patent Network Europe 2018

Thursday, November 15, 2018
8:00 AM - 8:30 AM	Registration, Welcome Coffee and Networking
8:50 AM - 9:00 AM	Chairman's Opening Address Anita Varma, Partner, White & Case LLP
9:00 AM - 9:30 AM	Global Patent Protection: Market Status and Outlook Recent Case Law Round-up and Policy Direction from Americas, Europe and Asia Anita Varma, Partner, White & Case LLP
9:30 AM - 10:00 AM	Corporations Share Legal Challenges: Securing and Protecting Patents What are the day-to-day challenges for in-house counsel in securing IP rights? What do we need from private practice attorneys? Infringement: What should be our strategy in Patent Enforcement? Moderator: Leena Contarino, Partner, HGF Panellists: Sally Curran, Senior Director – Patent, AstraZeneca David Gallagher, Senior Vice President – Intellectual Property & Legal, TC Biopharm Sherry Carty, Director, IP, Profusa Steven Ward, Lead Patent Attorney, Syngenta
10:00 AM - 10:30 AM	Recent Developments at the European Patent Office Quality at the EPO Timeliness of Applications with the Policy of Early Certainty Extension States and the Patent Prosecution Highway Dealing with Asian Documentation Peter Albrecht, Principal Director Operations, European Patent Office
10:30 AM - 10:55 AM	A Perspective on Recent UK Supreme Court Caselaw Chris de Mauny, Associate, Barrister, Bird & Bird
10:55 AM - 11:20 AM	Building a Robust Patent Portfolio: Value Creation and Cost Management Sherry Carty, Director, Intellectual Property, Profusa
11:20 AM - 11:50 AM	Morning Coffee & Networking
11:50 AM - 12:10 PM	Brexit: the IPO, the UPC and Future European Regulatory Divergence Will the German Constitutional Case stop the UPC in its tracks? What will happen to the Unified Patent Court when the UK leaves the EU? How Might Existing and Future European Directives be Applied to Questions of Patentability and Patent Enforceability? Global Harmonisation: What’s the likely impact of Brexit on Regulatory Divergence? What steps are IP firms and corporate patent counsel taking to address Brexit? How can private practice attorneys reassure them? Marianne Schaffner, Partner, Dentons
12:10 PM - 12:40 PM	Panel Discussion: Supplementary Protection Certificates Should potential SPC applicants apply early under the existing EU rules or wait for new UK rules to come into force Where do the precise boundaries of SPC law fall? Moderator: Mike Gilbert, Partner, Marks & Clerk Panellists: Elena Böhles, Assistant Counsel, MSD Steven Ward, Lead Patent Attorney, Syngenta Andy Porter, Director - Chief Technical Officer, Elasmogen
12:40 PM - 1:00 PM	Supplementary Protection Certificates: A Case Study Oliver Kingsbury, Partner - UK & European Patent Attorney, Elkington + Fife
1:00 PM - 1:15 PM	How Do We Ensure the Effective Protection of Antibodies? Johan Renes, Partner, DLA Piper
1:15 PM - 2:15 PM	Lunch and Networking in the Exhibition Hall
2:15 PM - 2:20 PM	Roundtable Discussion Groups Please select your preferred roundtable topic for rotation 1. We will endeavour to place you on your preferred table, however places will be allocated on a first come first served basis.
2:20 PM - 3:05 PM	Actavis and Equivalence: Where are we now? Douglas Drysdale, Partner, HGF	How do we Ensure Effective Protection of Antibodies? Jennifer O’Farrell, Partner, Boult Wade Tennant	IP Considerations in M&A Andy Porter, Director - Chief Technical Officer, Elasmogen	Best Practices in IP Portfolio Management Surbhi Gupta, Director, IP and Operations, Precision Robotics	Life Sciences Patents Open Clinic: Solving in-house Counsel Challenges Oliver Kingsbury, Partner, UK & European Patent Attorney, Elkington + Fife	Overcoming Legal Hurdles in CRISPR Gene Editing Rebecca Baines, Partner, FieldFisher Beatriz San Martin, Partner, FieldFisher	Strategies in Second Medical Use Cases Gabriel Cuonzo & Daniela Ampollini, Trevisan & Cuonzo	Supplementary Protection Certificates: A European Overview David Holland, Partner, Carpmaels & Ransford
3:05 PM - 3:10 PM	Roundtable Discussion Groups Please select your preferred roundtable topic for rotation 2. We will endeavour to place you on your preferred table, however places will be allocated on a first come first served basis.
3:10 PM - 3:50 PM	Actavis and Equivalence: Where are we now? Douglas Drysdale, Partner, HGF	How do we Ensure Effective Protection of Antibodies? Jennifer O’Farrell, Partner, Boult Wade Tennant	IP Considerations in M&A Andy Porter, Director - Chief Technical Officer, Elasmogen	Best practice in IP portfolio management Surbhi Gupta, Director, IP and Operations, Precision Robotics	Life Sciences Patents Open Clinic: Solving in-house Counsel Challenges Oliver Kingsbury, Partner, UK & European Patent Attorney, Elkington + Fife	Overcoming Legal Hurdles in CRISPR Gene Editing Rebecca Baines, Partner, FieldFisher Beatriz San Martin, Partner, FieldFisher	Strategies in Second Medical Use Cases Gabriel Cuonzo & Daniela Ampollini, Trevisan & Cuonzo	Supplementary Protection Certificates: A European Overview David Holland, Partner, Carpmaels & Ransford
3:50 PM - 4:00 PM	Discussion Group Round-up: Key Findings and Points of Note
4:00 PM - 4:20 PM	Afternoon Tea and Networking in the Exhibition Hall
4:20 PM - 4:45 PM	Second Medical Use Patents: A US Perspective Matt Mulkeen, Patent Attorney, Novartis Pharmaceuticals
4:45 PM - 5:00 PM	Pharma Patent Litigation in Russia Natalia Gulyeva, Partner, Hogan Lovells
5:00 PM - 5:30 PM	The Impact of AI in Healthcare: Activities, Pitfalls and Opportunities The Players and Leaders An Examination of Eight Areas of Activity, with examples of where AI is being used today with some success Identifying the potential pitfalls - and the IP opportunities that AI presents Patrick Courtney, Board Member, Standards in Laboratory Automation
5:30 PM - 6:30 PM	Chairman’s Closing Remarks and Life Sciences Patent Network Drinks Reception Anita Varma, Partner, White & Case LLP

PROTECTING INNOVATION IN A CHANGING LANDSCAPE

Share on social: